Single Dose Study of MK-2214 in Healthy Japanese Participants

Phase 1

Recruiting

• Conditions: Alzheimer's Disease

• Registration Number: JPRN-jRCT2031220627
• Lead Sponsor: Tanaka Yoshiyuki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-02-09
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Healthy male or female aged 18 to 75 years old with BMI 18 to 30 kg/m2

Exclusion Criteria

Has a history of clinically significant abnormalities or diseases

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adverse event

Secondary Outcome Measures

Name	Time	Method
AUC0-inf, AUC0-last, AUC0-140d, AUC0-28d, Cmax, Tmax, t1/2, CL and Vz